Ciencias de la Salud
Campo de conocimiento
University of Ulm
Ulm, AlemaniaPublicaciones en colaboración con investigadoras/es de University of Ulm (25)
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2017
-
Global, regional, and national age-sex specifc mortality for 264 causes of death, 1980-2016: A systematic analysis for the Global Burden of Disease Study 2016
The Lancet, Vol. 390, Núm. 10100, pp. 1151-1210
-
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: A systematic analysis for the Global Burden of Disease Study 2016
The Lancet, Vol. 390, Núm. 10100, pp. 1084-1150
-
Healthcare access and quality index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: A novel analysis from the global burden of disease study 2015
The Lancet, Vol. 390, Núm. 10091, pp. 231-266
2016
2015
-
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
The Lancet, Vol. 385, Núm. 9963, pp. 117-171
-
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: Quantifying the epidemiological transition
The Lancet, Vol. 386, Núm. 10009, pp. 2145-2191
-
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
The Lancet, Vol. 386, Núm. 9995, pp. 743-800
-
SCN4A pore mutation pathogenetically contributes to autosomal dominant essential tremor and may increase susceptibility to epilepsy
Human Molecular Genetics, Vol. 24, Núm. 24, pp. 7111-7120
2014
-
Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicenter, randomized double-masked, placebo-controlled trials
Diabetes Technology and Therapeutics
2013
-
Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicentre, randomised, double-blind, placebo-controlled trials
The Lancet, Vol. 381, Núm. 9881, pp. 1905-1915
-
Lessons from the Hvidoere International Study Group on childhood diabetes: Be dogmatic about outcome and flexible in approach
Pediatric Diabetes, Vol. 14, Núm. 7, pp. 473-480
-
MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis
Brain, Vol. 136, Núm. 6, pp. 1778-1782
2012
-
Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: Their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice
Neurobiology of Aging, Vol. 33, Núm. 11, pp. 2641-2660
-
Transgenic expression of intraneuronal Aβ42 but not Aβ40 leads to cellular Aβ lesions, degeneration, and functional impairment without typical Alzheimer's disease pathology
Journal of Neuroscience, Vol. 32, Núm. 4, pp. 1273-1283
2011
-
Global analysis of breast feeding and risk of symptoms of asthma, rhinoconjunctivitis and eczema in 6-7 year old children: ISAAC Phase Three
Allergologia et Immunopathologia, Vol. 39, Núm. 6, pp. 318-325
2010
-
The impact of the method of consent on response rates in the ISAAC time trends study
International Journal of Tuberculosis and Lung Disease, Vol. 14, Núm. 8, pp. 1059-1065
2009
-
Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances
Neurobiology of Aging, Vol. 30, Núm. 12, pp. 1936-1948